| |
Ziment Multi-Client Launch and Appointments
New York-based healthcare and pharmaceutical specialist The Ziment Group has launched IMAP Research, a new division specialising in multi-client studies. The Group also announced two senior appointments in Europe.
According to Group Chief Exec Howard Ziment, 'Our clients are looking more and more towards multi-client solutions when it comes to having an ongoing understanding of the therapeutic marketplaces in which their products compete... IMAP will set new standards for multi-client offerings by leveraging the physical and intellectual capital already at hand within the Ziment Group. Powered by WebSurveyResearch and the Ziment Chronic Illness Internet panels, this division has instant access to over 75,000 physicians and 400,000 patients from around the globe... unprecedented in this space'.
IMAP becomes the Group's third division, alongside full service custom research consultancy Ziment and online physicians panel operator WebSurveyResearch.
The two new European appointments are Andrew Scott, who becomes MD of Ziment Europe, having spent the last 23 years at NOP World Health in London, most recently as the Deputy MD; and Andrea Manemann as Manager of Client Service, based in Stuttgart, having worked for Sanofi-Synthelabo in Berlin as a Product Market Researcher for the past six years.
The Ziment Group is the global healthcare research brand for The Kantar Group, and is on the Web at www.ziment.com
|
